Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Eribulin|DRUG: Trastuzumab|DRUG: pertuzumab|DRUG: Pyrotinib|DRUG: Pembrolizumab|DRUG: Camerlizumab
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University